Anti-AQP4 antibody in idiopathic acute transverse myelitis with recurrent clinical course: Frequency of positivity and influence in prognosis

Journal of Spinal Cord Medicine

Volumn 35, Issue 4, 2012, Pages 251-255

  Alvarenga, Marina Papais ^a   Alvarenga, Regina Maria Papais ^a,b   Alvarenga, Marcos Papais ^a,b   Santos, Adriano Miranda ^a   Thuler, Luiz Claudio Santos ^a,c  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL DA LAGOA   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Anti AQP4 antibody; Demyelinating diseases; Disability; Multiple sclerosis; Neuromyelitis optica; Paresis; Transverse myelitis

Indexed keywords

AQUAPORIN 4 ANTIBODY; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY; AUTOANTIGEN;

ADOLESCENT; ADULT; AFRICA; ARTICLE; BRAZIL; CHILD; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS; MALE; MEDICAL RECORD REVIEW; MULTIPLE SCLEROSIS; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RECURRENT DISEASE; SCHOOL CHILD; SPINAL CORD LESION; VERTEBRA; BLOOD; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AQUAPORIN 4; AUTOANTIBODIES; AUTOANTIGENS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELITIS, TRANSVERSE; PROGNOSIS; RECURRENCE; YOUNG ADULT;

EID: 84865813503     PISSN: 10790268     EISSN: 20457723     Source Type: Journal    
DOI: 10.1179/2045772312Y.0000000019     Document Type: Article

References (18)

1. Wingerchuk DM, Weinshenker BG. Unusual presentations and variants of central nervous system idiopathic demyelinating diseases. In: Raine CS, McFarland HF, Hohlfeld R. (eds.) Multiple sclerosis. A comprehensive text. Saunders Elsevier: Philadelphia, PA, USA, 2008. p. 24-42.
2. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002;59(4):499-505.
3. Scott TF, Kassab SL, Singh S. Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler 2005;11(4):373-7. (Pubitemid 40984228)
4. Ford B, Tampieri D, Francis G. Long-term follow-up of acute partial transverse myelopathy. Neurology 1992;42(1):250-2.
5. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6(9):805-15. (Pubitemid 47238676)
6. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Luchinetti CF, Fujihara CF, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364(9451):2106-12. (Pubitemid 39626806)
7. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Luchinetti CF, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006;59(3):566-9. (Pubitemid 43358081)
8. Scott TF, Kassab SL, Pittock SJ. Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol 2006;63(10):1398-400. (Pubitemid 44547550)
9. Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F, et al. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol 2007;254(9):1233-7. (Pubitemid 350112363)
10. Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007;68(13):1076-7. (Pubitemid 46569147)
11. Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med 2007;4(4):e133.
12. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008;65(7):913-9. (Pubitemid 352008474)
13. Marigner R, De Seze J, Vukusic S, Durand-Dubief F, Zéphir H, Vermersch P, et al. NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult Scler 2008;14(4):440-5. (Pubitemid 351943855)
14. Fazio R, Malosio V, Lampasona D, De Feo D, Privitera F, Marnetto D, et al. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler 2009;15(10):1153-63.
15. Alvarenga MP, Thuler LC, NETO SP, Vasconcelos CC, Camargo SG, Alvarenga MP, et al. The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro. J Neurol 2010;257(6):992-8.
16. Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006;77(9):1073-5. (Pubitemid 44338534)
17. Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007;130(Pt 5):1206-23. (Pubitemid 47355945)
18. Kim SH, Kim SM, Vincent A, Ahn SW, Hong YH, Park KS, et al. Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis. J Neurol 2010;257:920-5.